Adocia (OTCMKTS:ADOCY – Get Free Report) will likely be announcing its resultson Thursday, September 24th. Analysts expect Adocia to post earnings of ($0.6609) per share for the quarter.
Adocia Stock Performance
Shares of ADOCY opened at $11.80 on Tuesday. Adocia has a 52 week low of $9.80 and a 52 week high of $11.80. The company has a current ratio of 1.19, a quick ratio of 1.17 and a debt-to-equity ratio of 4.18. The stock has a 50 day moving average of $11.80 and a 200-day moving average of $11.80.
About Adocia
Adocia is a biopharmaceutical company based in Lyon, France, focused on developing innovative formulations of therapeutic proteins and peptides. The company’s research is centered on its proprietary BioChaperone technology, which is designed to improve the solubility, stability, absorption and delivery of biologic medicines.
Adocia has primarily targeted diabetes and metabolic diseases, developing insulin-based treatments and combination therapies intended to improve blood-glucose management and patient convenience.
Further Reading
- Five stocks we like better than Adocia
- Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?
- Coach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback
- AI Is Reshaping SaaS—These 2 Software ETFs Offer Different Ways to Play It
- Insiders Signal Deep Value In DICK’s Sporting Goods
Receive News & Ratings for Adocia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adocia and related companies with MarketBeat.com's FREE daily email newsletter.
